Proscia

Proscia's Concentriq platform is designed for digital pathology, focusing on AI applications for cancer diagnostics and drug development. Rated #1 in the 2026 Best in KLAS, Concentriq connects various workflows and enhances diagnostic capabilities across the lifecycle of drug development.

The platform includes three main products: Concentriq LS for life sciences, Concentriq AP for anatomic pathology, and Concentriq AP-Dx for primary diagnosis. These products offer advanced digitization, seamless interoperability, and intuitive interfaces for managing cases. Proscia also emphasizes the importance of real-time insights, allowing pathologists and scientists to make informed decisions swiftly.

Proscia aims to help laboratories transition to fully digital processes, increasing efficiency and improving diagnostic accuracy. With features tailored to enhance research and clinical trials, Concentriq is positioned to support organizations looking to innovate in precision medicine.